PLM-101

CAT: 0013-GTR19230856-01Size: 50 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19230856-01Size:50 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

PLM-101 is an orally active small molecule anticancer agent targeting FLT3 and RET for acute myeloid leukemia research. It induces FLT3 degradation via autophagy and inhibits PI3K and Ras/ERK signaling. Its efficacy has been validated in vitro and in vivo, including in mouse MV4-11 xenograft models at oral doses of 3-40 mg/kg.

Field of Research

Cardiovascular Research, Cell Biology, Signal Transduction

Molecular Formula

C22H22FN5O2

Molecular Weight

407.44

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR18890273	PLM derived peptide
GTR19066967-01	PLM derived peptide
GTR18903962-01	PLM derived peptide
GTR18978772	PLM Antibody Blocking peptide
GTR18332980-01	Phospho-PLM (S68) Antibody
GTR19212715-01	Plm IV inhibitor-2
GTR19160965-01	AT-101
GTR18290294-01	PLM (Phospho-S68) monoclonal antibody
GTR18332524-01	Mouse PLM Antibody (N-term)
GTR19154306-01	AT-101

Alternative Products

Catalog	Name
MBS5820532	PLM-101
C45574-01	PLM Antibody
PE-86697-01	PLM Derived Peptide
AF6786-01	FXYD1/PLM Antibody
RA34142-01	PLM rabbit pAb
AF6786-BP	FXYD1/PLM Peptide
abx025160-01	PLM (pS68) Antibody
55-749	M PLM Antibody
JOT-AP12020-01	PLM Rabbit Polyclonal Antibody
HY-148034	Plm IV inhibitor-1

PLM-101

Related Products

Alternative Products

Popular Products